Evidence map›Paper›PMID 24937328›Full record

ArticlePloS one2014

Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn's disease in a Chinese family study.

Shufang Xu, Feng Zhou, Jinsheng Tao, Lu Song, Siew Chien Ng, Xiaobing Wang, Liping Chen, Fengming Yi, Zhihua Ran, Rui Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. In Vitro Models for Investigating Intestinal Host-Pathogen Interactions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shufang XuDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China.
Feng ZhouDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China; Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People's Republic of China.
Jinsheng TaoBGI-Shenzhen, Bei Shan Industrial Zone, Yantian District, Shenzhen, People's Republic of China.
Lu SongDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China.
Siew Chien NgInstitute of Digestive Disease, Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
Xiaobing WangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China.
Liping ChenDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China; Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People's Republic of China.
Fengming YiDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China.
Zhihua RanDepartment of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Rui ZhouHubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People's Republic of China.
Bing XiaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China; Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, and Hubei Key Laboratory of Immune Related Diseases, Wuhan, People's Republic of China.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNBGI Group (China) · CNChinese University of Hong Kong · CNRenji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic variants make some contributions to inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). More than 100 susceptibility loci were identified in Western IBD studies, but susceptibility gene has not been found in Chinese IBD patients till now. Sequencing of individuals with an IBD family history is a powerful approach toward our understanding of the genetics and pathogenesis of IBD. The aim of this study, which focuses on a Han Chinese CD family, is to identify high-risk variants and potentially novel loci using whole exome sequencing technique.

methodsExome sequence data from 4 individuals belonging to a same family were analyzed using bioinformatics methods to narrow down the variants associated with CD. The potential risk genes were further analyzed by genotyping and Sanger sequencing in family members, additional 401 healthy controls (HC), 278 sporadic CD patients, 123 UC cases, a pair of monozygotic CD twins and another Chinese CD family.

resultsFrom the CD family in which the father and daughter were affected, we identified a novel single nucleotide variant (SNV) c.374T>C (p.I125T) in exon 4 of discs large homolog 1 (DLG1), a gene has been reported to play multiple roles in cell proliferation, T cell polarity and T cell receptor signaling. After genotyping among case and controls, a PLINK analysis showed the variant was of significance (P<0.05). 4 CD patients of the other Chinese family bore another non-synonymous variant c.833G>A (p.R278Q) in exon 9 of DLG1.

conclusionsWe have discovered novel genetic variants in the coding regions of DLG1 gene, the results support that DLG1 is a novel potential susceptibility gene for CD in Chinese patients.

Indexed as

ExomeAdaptor Proteins, Signal TransducingAdolescentAdultBase SequenceCase-Control StudiesChinaCrohn DiseaseDiscs Large Homolog 1 ProteinDNA Mutational AnalysisFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansINDEL MutationMaleAdaptor Proteins, Signal TransducingDiscs Large Homolog 1 ProteinDLG1 protein, humanMembrane Proteins

Identifiers

PMID24937328
PMCPMC4061034
OpenAlexW2063802282

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.